Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v12-FR Version v10-FR
Language French French
Date Updated 2020-06-22 2020-06-01
Drug Identification Number 01918346 01918346
Brand name COUMADIN TAB 2.5MG COUMADIN TAB 2.5MG
Common or Proper name Warfarin Warfarin
Company Name BRISTOL-MYERS SQUIBB CANADA BRISTOL-MYERS SQUIBB CANADA
Ingredients WARFARIN SODIUM WARFARIN SODIUM
Strength(s) 2.5MG 2.5MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 1 BTL x 250 1 BTL x 250
ATC code B01AA B01AA
ATC description ANTITHROMBOTIC AGENTS ANTITHROMBOTIC AGENTS
Reason for discontinuation Manufacturing issues Manufacturing issues
Anticipated discontinuation date 2020-07-15 2020-07-15
Actual discontinuation date 2020-08-31 2020-08-31
Remaining supply date 2020-08-31 2020-08-31
Discontinuation status To be discontinued To be discontinued
Discontinuation decision reversal no no
Information on remaining supply
Company comments
Health Canada comments